Transfusion-transmitted emerging infectious diseases: 30 years of challenges and progress.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Transfusion-transmitted arboviruses: Update and systematic review.PLoS neglected tropical diseases · 2022
   Pooled it
2. Pathogen-reduced plasma, cryoprecipitate reduced for therapeutic plasma exchange.Transfusion · 2026
   Article
3. Animal vaccine strain Brucella abortus infection in a plateletpheresis donor: A case report.Transfusion · 2024
   Article
4. Establishment of a keratinocyte and fibroblast bank for clinical applications in Japan.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2023
   Article
5. Patterns of Hepatitis B, Hepatitis C and HIV Among Blood Donors in Samtah-Jazan Region.Journal of epidemiology and global health · 2022
   Article
6. A Conserved Receptor-Binding Domain in the VP1u of Primate Erythroparvoviruses Determines the Marked Tropism for Erythroid Cells.Viruses · 2022
   Article
7. The VP1u of Human Parvovirus B19: A Multifunctional Capsid Protein with Biotechnological Applications.Viruses · 2020
   Review
8. Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026).Transfusion · 2019
   Article
9. Amustaline-glutathione pathogen-reduced red blood cell concentrates for transfusion-dependent thalassaemia.British journal of haematology · 2019
   Article
10. Transfusion of pathogen-reduced platelet components without leukoreduction.Transfusion · 2019
    Article
11. Economic Implications of Pathogen Reduced and Bacterially Tested Platelet Components: A US Hospital Budget Impact Model.Applied health economics and health policy · 2018
    Article
12. First detection of human hepegivirus-1 (HHpgV-1) in Iranian patients with hemophilia.Scientific reports · 2018
    Article
13. Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology.Blood transfusion = Trasfusione del sangue · 2017
    Review
14. Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk.Transfusion medicine reviews · 2017
    Review
15. On risk appraisal of behaviour.Blood transfusion = Trasfusione del sangue · 2016
    Article
16. Research on the human virome: where are we and what is next.Microbiome · 2016
    Article
17. Transfusion-transmissible infection monitoring system: a tool to monitor changes in blood safety.Transfusion · 2016
    Article
18. Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium.Transfusion medicine reviews · 2016
    Article
19. Blood donor selection in European Union directives: room for improvement.Blood transfusion = Trasfusione del sangue · 2016
    Article
20. The Prevention of Periprosthetic Joint Infections.The open orthopaedics journal · 2016
    Review

Corrections and comments

• Comment on
  Emerging infectious disease agents and their potential threat to transfusion safety.2009

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as